Search

Baris E Polat

from Morgantown, WV
Age ~41
Get Report
Also known as:
Baris Erinc Polat, Baris Julia Polat, Baris Osman Polat, Baris D Polat, Premavalli Shanmugam, Polat Baris, Shanmugam Premavalli
Connected to:
Anil O Polat, 44Aytekin Polat, 58Cengiz Polat, 60Deniz N Polat, 36Erkan Polat, 37Hakan Polat, 45Oded Polat, 43Tolga Polat, 46George M Polatas, 62Jacob N Polatin, 75

Baris Polat Phones & Addresses

  • Morgantown, WV
  • 4 Jaycee Dr, Pittsburgh, PA 15243 (412) 276-4151
  • Buffalo Grove, IL
  • Montgomery, OH
  • 300 Allston St, Brighton, MA 02135
  • Midland, MI

Resumes

Resumes

Baris Polat Photo 1

Senior Director, Global Osd Operations

View page
Location:
329 Villa View Dr, Morgantown, WV 26505
Industry:
Pharmaceuticals
Work:
Mylan Nov 2017 - Jul 2019
Director, Global Osd Operations Management
Mylan Nov 2017 - Jul 2019
Senior Director, Global Osd Operations Management
Mylan Aug 2016 - Nov 2017
Director, 3P Technical Services and Strategic Operations Global Complex Products
Mylan Dec 2014 - Aug 2016
Director - Global Complex Products Strategic Manufacturing
Mylan Mar 2014 - Dec 2014
Lead Formulation Scientist, Product Development
Education:
Massachusetts Institute of Technology 2005 - 2011
Doctorates, Doctor of Philosophy, Chemical Engineering Carnegie Mellon University 2001 - 2005
Bachelors, Bachelor of Science, Chemical Engineering Sycamore High School 1997 - 2001
Skills:
Formulation
Drug Delivery
R&D
Pharmaceutical Industry
Technology Transfer
Biotechnology
Chemical Engineering
Manufacturing
Nanotechnology
Validation
Transdermal
Quality By Design
Biomaterials
Technical Writing
Languages:
Turkish
Baris Polat Photo 2

Baris Polat

View page
Location:
United States

Publications

Us Patents

Microneedle Devices And Uses Thereof

View page
US Patent:
20130165772, Jun 27, 2013
Filed:
Dec 27, 2012
Appl. No.:
13/728300
Inventors:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA, US
THE GENERAL HOSPITAL CORPORATION - Boston MA, US
Baris Erinc Polat - Brighton MA, US
Carl Magnus Schoellhammer - Santa Monica CA, US
Daniel Blankschtein - Brookline MA, US
Daniel G. Anderson - Sudbury MA, US
Robert S. Langer - Newton MA, US
Assignee:
THE GENERAL HOSPITAL CORPORATION - Boston MA
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
International Classification:
A61M 37/00
A61M 5/00
US Classification:
600431, 604173, 604506, 604 22, 604 20, 600 9
Abstract:
The present disclosure provides devices and uses thereof A devices disclosed herein comprises a plurality of microneedles adapted to protrude from the device. In some embodiments, a device is dimensioned and constructed to carry a payload, so that the payload can be delivered to an internal tissue of a subject or through a wall of a vessel after interaction with microneedles. In some embodiments, devices can be used for oral or intravenous administration. In some embodiments, devices can be used for implantation such as vaginal, rectal, urethral or bladder suppository or pessary.

Systems, Apparatus, And Methods For Administering A Substance

View page
US Patent:
20180055991, Mar 1, 2018
Filed:
Oct 6, 2017
Appl. No.:
15/727015
Inventors:
Carl Magnus SCHOELLHAMMER - Somerville MA, US
Carlo Giovanni TRAVERSO - Newton MA, US
Avraham SCHROEDER - Binyamina, IL
Baris POLAT - Pittsburgh PA, US
Daniel BLANKSCHTEIN - Brookline MA, US
Robert S. LANGER - Newton MA, US
William BRUGGE - Boston MA, US
International Classification:
A61M 3/02
A61M 37/00
A61M 31/00
Abstract:
Apparatus, kits, and methods for administering a substance are presented. A device for administering a substance includes an elongated body having a proximal end and a distal end, the elongated body defining an internal chamber extending between the proximal end and the distal end to direct the substance to the distal end, the distal end to connect with a tip, the tip to be at least partially inserted into an orifice of a body lumen of a subject, the tip having a shape configured to reduce leakage of the substance from the orifice upon the at least partial insertion. The tip includes an opening to pass the substance from the internal chamber into the body lumen; and a transducer to emit an ultrasound wave from the tip into the body lumen, thereby administering the substance to tissue in the body lumen.

Method And Apparatus For Delivering A Substance

View page
US Patent:
20140228715, Aug 14, 2014
Filed:
May 14, 2012
Appl. No.:
14/116628
Inventors:
- Boston MA, US
- Cambridge MA, US
Baris E. Polat - Brighton MA, US
Kathryn A. Whitehead - Somerville MA, US
Daniel G. Anderson - Sudbury MA, US
Carl Magnus Schoellhammer - Santa Monica CA, US
Daniel Blankschtein - Brookline MA, US
Assignee:
The General Hospital Corporation - Boston MA
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61N 7/00
US Classification:
601 2
Abstract:
A method of delivering a substance includes providing a substance at a location in a gastrointestinal (GI) tract, excluding a buccal membrane, of a biological body; and applying ultrasonic waves, having a frequency between about 20 kHz and about 10 MHz, at the location. The method can include storing the substance in at least one reservoir and exposing a medium within or of the GI tract to the substance. The method can further include delivering a device into the GI tract, the device including at least one ultrasound transducer and circuitry; powering the at least one ultrasound transducer and circuitry from within the device; and driving the at least one ultrasound transducer, using the circuitry, in a manner causing the at least one ultrasound transducer to emit ultrasonic waves to a medium within or of the GI tract.

Levothyroxine Formulation With Acacia

View page
US Patent:
20140178511, Jun 26, 2014
Filed:
Dec 21, 2012
Appl. No.:
13/723485
Inventors:
- Canonsburg PA, US
Ramakrishna Nallamothu - Morgantown WV, US
Baris E. Polat - Morgantown WV, US
Assignee:
Mylan Inc. - Canonsburg PA
International Classification:
A61K 31/198
A61K 31/235
A61K 31/085
A61K 36/48
US Classification:
424769
Abstract:
A pharmaceutical composition comprising thyroxine, acacia, and an antioxidant selected from propyl gallate, butylated hydroxyanisol, and butylated hydroxytoluene is disclosed. The pharmaceutical composition has an improved shelf life. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.

Levothyroxine Formulation With Carrageenan

View page
US Patent:
20140179784, Jun 26, 2014
Filed:
Dec 21, 2012
Appl. No.:
13/723500
Inventors:
- Canonsburg PA, US
Ramakrishna Nallamothu - Morgantown WV, US
Baris E. Polat - Morgantown WV, US
Assignee:
Mylan Inc. - Canonsburg PA
International Classification:
A61K 47/36
US Classification:
514567
Abstract:
A pharmaceutical composition comprising thyroxine and carrageenan. The pharmaceutical composition has an improved shelf life compared to other pharmaceutical compositions containing thyroxine. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.
Control profile
Baris E Polat from Morgantown, WV, age ~41 Get Report